Each year, the CTRC-AACR San Antonio Breast Cancer Symposium attracts academic and private physicians and researchers, as well as other health care professionals focused on curing breast cancer, to discuss and learn about new and late-breaking research including experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and pre-malignant breast disease, as well as new findings from clinical trials. Courtesy of the American Association for Cancer Research

San Antonio, USA - December 10, 2010

33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium

"An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer."

The 2010 CTRC-AACR San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine.

The driving force behind this collaboration is the shared mission of the organizations to advance progress against breast cancer.
By combining their respective strengths, the San Antonio Breast Cancer Symposium will encompass the full spectrum of breast cancer research and facilitate the rapid transition of new knowledge into improved care for breast cancer patients.


Overview

This symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

Courtesy of the American Association for Cancer Research / YouTube

The scientific program consists of invited lectures and mini-symposia by experts in clinical and basic research, selected slide and poster presentations, and case discussions are chosen from the submitted abstracts.

Courtesy of the American Association for Cancer Research / YouTube

General sessions are 2-3 hours in duration and are the vehicle for slide presentations, which are allotted 10 minutes each followed by 5 minutes for discussion.
Poster sessions are each 2 hours long.


Target Audience

This international symposium is directed primarily towards academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as other appropriate health care professionals.

http://www.ctrc.net/ctrc_2_2.cfm?db_content=sabcs  

About the Cancer Therapy & Research Center

Mission

The mission of the Cancer Therapy & Research Center is to conquer cancer through research, prevention and treatment.

Vision

To be one of the world’s premier cancer research and treatment centers dedicated to the development of novel therapies, compassionate and comprehensive care, outreach to the diverse communities we serve, prevention of disease and promotion of wellness, and an uncompromising commitment to understanding the complex nature of cancer, its causes and consequences.

World-class comprehensive care

CTRC's total patient care system which consists of break-through research, state-of-the-art tools and technology and multidisciplinary clinical care delivered through a team of world-class physicians, laboratory scientists and other medical professionals allows it to seamlessly translate the latest research findings more efficiently and directly to patients.

We treat the cancer, and care for the patient.
And our scientists and doctors are committed to conquering cancer one patient at a time.

History

The Cancer Therapy & Research Center, one of the nation’s premier cancer centers, first opened its doors in 1974 as a 501(c)(3) nonprofit corporation dedicated to providing the community with outpatient radiation therapy.
More than four decades later, CTRC continues to serve – in a vastly expanded capacity – residents of San Antonio and South Texas, as well as patients from across the U.S., northern Mexico and other countries around the globe.

Courtesy of Cancer Therapy & Research Center

The organization got its start in 1972 as the Radiation Therapy & Research Foundation of South Texas.
Two years later, it opened its doors as the Cancer Therapy & Research Center on a two-acre tract adjacent to Methodist Hospital.
Adding medical oncology (chemotherapy) to the treatment offerings, the facility soon needed room to expand and obtained rights from the San Antonio Medical Foundation to 14 acres at the corner of Wurzbach and Floyd Curl drives.

The Cancer Therapy & Research Center (CTRC) and its Institute for Drug Development (IDD) are part of The University of Texas Health Science Center at San Antonio. Courtesy of Cancer Therapy & Research Center

Over the years the new campus, which opened in 1995, grew incrementally to include the interconnected Burton and Miriam Grossman Building, the Roger and Cherry Zeller Building, and the Urschel Tower, plus a 550-car parking garage.
As the square footage grew, so did the services offered, the expertise of the staff, and the affiliations that further broadened CTRC’s scope.

In 1991, CTRC launched its Institute for Drug Development.
By 1992, the IDD made its home in the Alice P. McDermott Building in the Texas Research Park located off of Potranco Road outside Loop 1604 on the San Antonio's West Side.
The IDD’s mission is to develop new treatments for patients with cancer through integration of research programs of excellence in the translational and clinical sciences.

The Cancer Therapy & Research Center (CTRC) at San Antonio. Photo: CTRC

Since its inception CTRC had collaborated in cancer treatment and prevention research with the University of Texas Health Science Center at San Antonio.
In 1991 the National Cancer Institute (a part of the National Institutes of Health) began funding the two institutions (know at that time as the San Antonio Cancer Institute or "SACI") as a designated cancer center.

The institute today maintains the prestigious designation as an NCI cancer center and is working toward reinstatement of comprehensive status.
The latter was withheld in 2001 with suggestions from NCI to focus more on translational research and population sciences.

On December 17, 2007, the CTRC became a center of the UT Health Science Center through authorization of The University of Texas System Board of Regents.
The San Antonio Cancer Institute name has been discontinued.
The CTRC at the UT Health Science Center is now the NCI-designated cancer center.

http://www.ctrc.net/ctrc_2_2.cfm?db_content=aboutus

http://www.ctrc.net/ctrc_2_2.cfm?db_content=history
 

About the American Association for Cancer Research

AACR Mission

The mission of the AACR is to prevent and cure cancer through research, education, communication, and collaboration.

Through its programs and services, the AACR fosters research in cancer and related biomedical science; accelerates the dissemination of new research findings among scientists and others dedicated to the conquest of cancer; promotes science education and training; and advances the understanding of cancer etiology, prevention, diagnosis, and treatment throughout the world.

Where will the cure for cancer come from?

The answer is research.
Cancer is not a single disease, but more than 200.

Courtesy of the American Association for Cancer Research / YouTube

In the U.S. and around the world, men and women in laboratories and clinics, universities, medical centers, government and industry, are working not only to overcome this affliction that claims half a million American lives each year, but also to prevent it.
More than 32,000 of them are members of the American Association for Cancer Research.

How does the AACR promote cancer research?

The AACR is the authoritative source of information about advances in the causes, diagnosis, treatment and prevention of cancer.
By accelerating the growth and spread of new knowledge about cancer, the AACR is on the front lines of the quest for prevention and cure.

What does the AACR do?

The AACR is the oldest and largest scientific organization in the world focused on every aspect of high-quality, innovative cancer research.
Its reputation for scientific breadth and excellence attract the premier researchers in the field.

The programs and services of the AACR foster the exchange of knowledge and new ideas among scientists dedicated to cancer research, provide training opportunities for the next generation of cancer researchers, and increase public understanding of cancer.

How did the AACR begin?

AACR was founded in 1907 by a group of 11 physicians and scientists interested in research, "to further the investigation and spread the knowledge of cancer."

Today, the AACR accelerates progress toward the prevention and cure of cancer by promoting research, education, communication, and collaboration.


Video
History of the American Association for Cancer Research (AACR)

http://www.youtube.com/watch?v=whxZb0OS_bE&feature  


Video
Cancer Research Saves Lives - American Association for Cancer Research

http://www.youtube.com/watch?v=LXcvytmU7so&feature  

The 33rd annual CTRC-AACR San Antonio Breast Cancer Symposium

Follow the AACR on Twitter @AACR, and throughout the meeting using the hash tag #SABCS.

Recordings of the teleconferences and video interviews with researchers will be posted to the AACR website throughout the meeting:

www.aacr.org/page23506.aspx  

The mission of the CTRC-AACR San Antonio Breast Cancer Symposium is to produce a unique and comprehensive scientific meeting that encompasses the full spectrum of breast cancer research, facilitating the rapid translation of new knowledge into better care for breast cancer patients.

The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, the American Association for Cancer Research (AACR) and Baylor College of Medicine are joint sponsors of the San Antonio Breast Cancer Symposium.

This collaboration utilizes the clinical strengths of the CTRC and Baylor, and the AACR’s scientific prestige in basic, translational and clinical cancer research to expedite the delivery of the latest scientific advances to the clinic.

The 33rd annual symposium is expected to draw nearly 9,000 participants from more than 90 countries.


Contact Media:

Jeremy Moore
(267) 646-0557
jeremy.moore@aacr.org

In San Antonio, Dec. 8-12:
(210) 582-7036


SOURCE:
http://www.aacr.org/



ASTROMAN Magazine - 2010.12.11

Combination Therapy Reduced HER2-positive Breast Cancers

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=855  


ASTROMAN Magazine - 2010.12.11

GlaxoSmithKline: Data from Tykerb investigational phase III studies

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=854